MedTrace Logo

Sensitivity of Fecal Immunochemical Test (FIT) for Colorectal Cancer (CRC) Screening

NCT05163236 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1149

Last updated 2021-12-20

No results posted yet for this study

Summary

Fecal immunochemical test (FIT) was introduced in France late 2015, FIT has better diagnostic accuracy for colorectal cancers (CRCs) than previous screening tests. Our primary objective was to evaluate the sensitivity of FIT and the proportion of interval cancer.

Conditions

  • Colorectal Neoplasms Malignant
  • Colonoscopy
  • Early Detection of Cancer
  • Female
  • Mass Screening
  • Middle Aged
  • Occult Blood

Interventions

DIAGNOSTIC_TEST

Positive fecal immunochemical test (FIT)

We evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.

DIAGNOSTIC_TEST

Negative fecal immunochemical test (FIT)

We evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.

DIAGNOSTIC_TEST

Fecal immunochemical test (FIT) not performed

We evaluated CRCs screening campaign from January 1, 2016 to December 31, 2017, and interval cancers within two years after a negative test, and five years for post-colonoscopy interval cancers.

Sponsors & Collaborators

  • Registre des Tumeurs Digestives du Finistère

    collaborator OTHER

  • Centre Régional de Coordination des Dépistages des Cancers Bretagne (CRCDC Bretagne)

    collaborator UNKNOWN

  • University Hospital, Brest

    lead OTHER

Principal Investigators

  • Michel ROBASZKIEWICZ · University Hospital, Brest

Eligibility

Min Age
50 Years
Max Age
77 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2021-10-11
Completion
2021-10-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05163236 on ClinicalTrials.gov